Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ethylcellulose

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ACIPHEX

    02 6RABEPRAZOLE SODIUM

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ALKEM LABS LTD

    RABEPRAZOLE SODIUM

    arrow
    2024 ACI Convention
    Not Confirmed
    ALKEM LABS LTD
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RABEPRAZOLE SODIUM

    Drug : RABEPRAZOLE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 208644

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AMNEAL PHARMS

    RABEPRAZOLE SODIUM

    arrow
    2024 ACI Convention
    Not Confirmed
    AMNEAL PHARMS
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RABEPRAZOLE SODIUM

    Drug : RABEPRAZOLE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 204179

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    CHARTWELL RX

    RABEPRAZOLE SODIUM

    arrow
    2024 ACI Convention
    Not Confirmed
    CHARTWELL RX
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RABEPRAZOLE SODIUM

    Drug : RABEPRAZOLE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 78964

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    RUBICON

    RABEPRAZOLE SODIUM

    arrow
    2024 ACI Convention
    Not Confirmed
    RUBICON
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RABEPRAZOLE SODIUM

    Drug : RABEPRAZOLE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 204237

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    TORRENT

    RABEPRAZOLE SODIUM

    arrow
    2024 ACI Convention
    Not Confirmed
    TORRENT
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RABEPRAZOLE SODIUM

    Drug : RABEPRAZOLE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 202376

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    WAYLIS THERAP

    RABEPRAZOLE SODIUM

    arrow
    2024 ACI Convention
    Not Confirmed
    WAYLIS THERAP
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RABEPRAZOLE SODIUM

    Drug : ACIPHEX

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 20973

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NORVIUM BIOSCIENCE

    RABEPRAZOLE SODIUM

    arrow
    2024 ACI Convention
    Not Confirmed
    NORVIUM BIOSCIENCE
    Country
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RABEPRAZOLE SODIUM

    Drug : RABEPRAZOLE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 76885

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF